Cancer imaging company buys Lisata for phase 2-stage solid tumor drug
Cancer imaging company buys Lisata for phase 2-stage solid tumor drug
Body unavailable. Use the original source.
Cancer imaging company buys Lisata for phase 2-stage solid tumor drug
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.